$Replacing 30 Gy in 10 fractions with stereotactic body radiation therapy for bone metastases: A large multi-site single institution experience 2016–2018$

Replacing 30 Gy in 10 fractions with stereotactic body radiation therapy for bone metastases: A large multi-site single institution experience 2016–2018

Background: Bone metastases cause significant morbidity in patients with cancer, and radiation therapy (RT) is an effective treatment approach. Indications for more complex ablative techniques are emerging. We sought to evaluate RT trends at a large multi-site tertiary cancer center. Methods: Patien...

Full description

Bibliographic Details
Main Authors:	Erin F. Gillespie, Kaitlyn Lapen, Diana G. Wang, N. Wijetunga, Gerri L. Pastrana, Marisa A. Kollmeier, Josh Yamada, Adam M. Schmitt, Daniel S. Higginson, Max Vaynrub, Ernesto Santos Martin, Amy J. Xu, C. Jillian Tsai, Divya Yerramilli, Oren Cahlon, T. Jonathan Yang
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	Clinical and Translational Radiation Oncology
Subjects:	Bone metastases Radiation therapy Stereotactic body radiation therapy End-of-life Palliative care
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405630820300811

Similar Items

Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial
by: Tanja Sprave, et al.
Published: (2018-08-01)

The role of stereotactic body radiation therapy in the treatment of colorectal liver metastases
by: Marinković Mladen, et al.
Published: (2022-01-01)

Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
by: Harun Badakhshi, et al.
Published: (2018-01-01)

Practice and principles of stereotactic body radiation therapy for spine and non-spine bone metastases
by: Laura Burgess, et al.
Published: (2024-03-01)

Immunological responses to brain metastasis stereotactic radiosurgery in patient-matched longitudinal blood and tumour samples
by: Joseph Sia, et al.
Published: (2024-11-01)

30-day mortality in patients treated for brain metastases: extracranial causes dominate
by: Carsten Nieder, et al.
Published: (2022-05-01)

Shifting paradigms: whole brain radiation therapy versus stereotactic radiosurgery for brain metastases
by: Ashwin Shinde, et al.
Published: (2019-03-01)

Considerations on surgery invasiveness and response and toxicity patterns in classic palliative radiotherapy for acrometastases of the hand: a hint for a potential role of stereotactic body radiation therapy? A case report and literature review
by: Gianluca Ferini, et al.
Published: (2023-06-01)

Case report: Stereotactic body radiation therapy with 12 Gy for silencing refractory ventricular tachycardia
by: Shan-Hui Huang, et al.
Published: (2022-11-01)

Single fraction stereotactic radiosurgery and fractionated stereotactic radiotherapy provide equal prognosis with overall survival in patients with brain metastases at diagnosis without surgery at primary site
by: Garett Paul Ostdiek-Wille, et al.
Published: (2023-05-01)

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases
by: Cyrielle Scouarnec, et al.
Published: (2019-08-01)

Stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic prostate cancer
by: Kamran Ali Ahmed, et al.
Published: (2013-01-01)

Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases
by: Laura Uder, et al.
Published: (2023-01-01)

Stereotactic body radiotherapy for osseous low alpha–beta resistant metastases for pain relief—SOLAR-P
by: Eric K. Nguyen, et al.
Published: (2021-09-01)

Spine Stereotactic Body Radiotherapy to Three or More Contiguous Vertebral Levels
by: Khaled Dibs, et al.
Published: (2022-06-01)

Scoring system predictive of survival for patients undergoing stereotactic body radiation therapy for liver tumors
by: Kress Marie-Adele S, et al.
Published: (2012-09-01)

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years
by: Khush S. Aujla, et al.
Published: (2019-02-01)

Stereotactic radiosurgery of brain metastases: a retrospective study
by: Isabella Gruber, et al.
Published: (2023-12-01)

Radiation therapy for melanoma brain metastases: a systematic review
by: Thompson John F., et al.
Published: (2022-08-01)

Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment Strategy
by: Chi-Leung Chiang, et al.
Published: (2019-11-01)

Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy
by: Paulina M. Gutkin, et al.
Published: (2023-03-01)

Individualized acromegaly treatment: Is stereotactic radiation therapy changing the paradigm?
by: Winnie Liu, et al.
Published: (2022-12-01)

Clinical characteristics of organizing pneumonia following stereotactic body radiation therapy for lung malignancies
by: Masayuki Ito, et al.
Published: (2017-02-01)

Feasibility, safety, and efficacy of circumferential spine stereotactic body radiotherapy
by: Khaled Dibs, et al.
Published: (2022-11-01)

Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients
by: Ming-Wei Ma, et al.
Published: (2022-10-01)

Stereotactic body radiation therapy for liver metastases from colorectal cancer: analysis of safety, feasibility, and early outcomes
by: Marie-Adele Sorel Kress, et al.
Published: (2012-02-01)

Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases
by: Theresa Voglhuber, et al.
Published: (2020-06-01)

Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking
by: Nathaniel Scher, et al.
Published: (2019-09-01)

CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer
by: Michael Waters, et al.
Published: (2024-01-01)

Use of palliative radiotherapy in brain and bone metastases (VARA II study)
by: Expósito Jose, et al.
Published: (2012-08-01)

Risk factors of local control in adrenal metastases treated by stereotactic body radiation therapy - a systematic review and meta-analysis
by: Xuehong Liao, et al.
Published: (2023-11-01)

Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients
by: Dazhen Jiang, et al.
Published: (2024-09-01)

Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Early Stage  Non-small Cell Lung Cancer
by: Lu CHEN, et al.
Published: (2014-04-01)

Preoperative stereotactic radiosurgery in the management of brain metastases and gliomas
by: Eric J. Lehrer, et al.
Published: (2022-10-01)

Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial
by: Christian D. Diehl, et al.
Published: (2019-11-01)

Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer
by: Seth R. Blacksburg, et al.
Published: (2020-12-01)

Long-term disease-free survival following comprehensive involved site radiotherapy for oligometastases
by: Johnny Kao, et al.
Published: (2023-12-01)

A pilot study of stereotactic boost for malignant epidural spinal cord compression: clinical significance and initial dosimetric evaluation
by: Elysia K. Donovan, et al.
Published: (2020-11-01)

Treatment trends in brain metastases from testicular cancer in the United States
by: Joseph Crooks, et al.
Published: (2023-12-01)

Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial
by: David M. Routman, et al.
Published: (2024-03-01)